Steward Partners Investment Advisory’s Praxis Precision Medicines PRAX Stock Holding History

Steward Partners Investment Advisory’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.22K	Buy	+10	New	+$3.09K	﹤0.01%	3921

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Steward Partners Investment Advisory's PRAX Position: Q1 2026 in Review

Steward Partners Investment Advisory opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 10 shares worth $3.22K. The stake represents ﹤0.01% of the portfolio and ranks #3921 among its holdings.

289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Steward Partners Investment Advisory held 10 shares of Praxis Precision Medicines worth $3.22K as of Q1 2026.
Praxis Precision Medicines was a new Steward Partners Investment Advisory position in Q1 2026.
Praxis Precision Medicines made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3921 holding.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.